These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29890213)

  • 1. Pathologic role of nitrergic neurotransmission in mood disorders.
    Ghasemi M; Claunch J; Niu K
    Prog Neurobiol; 2019 Feb; 173():54-87. PubMed ID: 29890213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide: Antidepressant mechanisms and inflammation.
    Ghasemi M
    Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders.
    Ghasemi M; Phillips C; Fahimi A; McNerney MW; Salehi A
    Neurosci Biobehav Rev; 2017 Sep; 80():555-572. PubMed ID: 28711661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems.
    Joca SR; Ferreira FR; Guimarães FS
    Stress; 2007 Aug; 10(3):227-49. PubMed ID: 17613938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflamed moods: a review of the interactions between inflammation and mood disorders.
    Rosenblat JD; Cha DS; Mansur RB; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():23-34. PubMed ID: 24468642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide: a novel link between synaptic and nonsynaptic transmission.
    Kiss JP; Vizi ES
    Trends Neurosci; 2001 Apr; 24(4):211-5. PubMed ID: 11250004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide signalling and antidepressant action revisited.
    Joca SRL; Sartim AG; Roncalho AL; Diniz CFA; Wegener G
    Cell Tissue Res; 2019 Jul; 377(1):45-58. PubMed ID: 30649612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
    Quesseveur G; Gardier AM; Guiard BP
    Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic deficit and mood disorders.
    Pania L; Gessab GL
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S1-7; discussion S7. PubMed ID: 12685916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NMDA receptors in the pathophysiology and treatment of mood disorders.
    Ghasemi M; Phillips C; Trillo L; De Miguel Z; Das D; Salehi A
    Neurosci Biobehav Rev; 2014 Nov; 47():336-58. PubMed ID: 25218759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?
    Abrial E; Lucas G; Scarna H; Haddjeri N; Lambás-Señas L
    Mol Neurobiol; 2011 Dec; 44(3):407-19. PubMed ID: 21983961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astroglial Connexin43 as a Potential Target for a Mood Stabiliser.
    Okada M; Oka T; Nakamoto M; Fukuyama K; Shiroyama T
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood disorders: regulation by metabotropic glutamate receptors.
    Pilc A; Chaki S; Nowak G; Witkin JM
    Biochem Pharmacol; 2008 Mar; 75(5):997-1006. PubMed ID: 18164691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide in the regulation of monoaminergic neurotransmission.
    Kiss JP
    Brain Res Bull; 2000 Aug; 52(6):459-66. PubMed ID: 10974484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding the intracellular signaling pathways affected by mood disorder treatments.
    Coyle JT; Duman RS
    Neuron; 2003 Apr; 38(2):157-60. PubMed ID: 12718851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms.
    West AR; Galloway MP; Grace AA
    Synapse; 2002 Jun; 44(4):227-45. PubMed ID: 11984858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder.
    Bielau H; Brisch R; Bernard-Mittelstaedt J; Dobrowolny H; Gos T; Baumann B; Mawrin C; Bernstein HG; Bogerts B; Steiner J
    Brain Res; 2012 Jun; 1459():91-9. PubMed ID: 22560594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythm and mood: relationships between the circadian clock and mood-related behavior.
    Schnell A; Albrecht U; Sandrelli F
    Behav Neurosci; 2014 Jun; 128(3):326-43. PubMed ID: 24660658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.